⌘K

Login Start Free

Home/Filings/4/0001209191-16-092267

4//SEC Filing

Anacor Pharmaceuticals, Inc. 4

Accession 0001209191-16-092267

CIK 0001411158operating

View on SEC.gov Company Profile

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 9:00 PM ET

Size

4.8 KB

Accession

0001209191-16-092267

Insider Transaction Report

Form 4

Period: 2016-01-15

Anacor Pharmaceuticals, Inc.ANAC

VP, Clinical Dev & Interim CMO

Transactions

Sale
Common Stock
2016-01-15$89.57/sh−1,466$131,310→ 27,281 total

Footnotes (1)

[F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Anacor Pharmaceuticals, Inc.

CIK 0001411158

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001411158

Filing Metadata

Form type: 4
Filed: Jan 18, 7:00 PM ET
Accepted: Jan 19, 9:00 PM ET
Size: 4.8 KB

View on SEC.gov